MARSHALL WACE, LLP – Horizon Therapeutics Public Limited Company Transaction History
MARSHALL WACE, LLP portfolio value:
$155.11M
portfolio value
MARSHALL WACE, LLP quarter portfolio value change:
-22.40%
quarter
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1481.33% | 2.34M shares | 142.47M | $61.89 | 2.50M |
| Q2 2022 | share | Decrease | -75.92% | -499.61K shares | -56.59M | $79.76 | 158.49K |
| Q1 2022 | share | Decrease | -60.28% | -998.57K shares | -109.28M | $105.21 | 658.10K |
| Q4 2021 | share | Increase | +3782.63% | 1.61M shares | 173.84M | $108.26 | 1.65M |
| Q3 2021 | share | Increase | 0.00% | 42.66K shares | 4.67M | $109.54 | 42.66K |
| Q2 2021 | share | Decrease | -100.00% | -3.09K shares | -285K | $93.64 | 0 |
| Q1 2021 | share | Decrease | -95.90% | -72.52K shares | -5.24M | $92.04 | 3.09K |
| Q4 2020 | share | Increase | +661.14% | 65.68K shares | 4.75M | $73.15 | 75.61K |
| Q3 2020 | share | Decrease | -91.30% | -104.30K shares | -5.57M | $77.68 | 9.93K |
| Q2 2020 | share | Increase | 0.00% | 114.24K shares | 6.35M | $55.58 | 114.24K |
| Q2 2019 | share | Decrease | -100.00% | -40.89K shares | -1.08M | $24.06 | 0 |
| Q1 2019 | share | Increase | 0.00% | 40.89K shares | 1.08M | $26.43 | 40.89K |